🇺🇸 FDA
Patent

US 11661599

CRISPR-Cas based system for targeting single-stranded sequences

granted A61KA61K31/7088A61K38/465

Quick answer

US patent 11661599 (CRISPR-Cas based system for targeting single-stranded sequences) held by The Regents of the University of California expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/7088, A61K38/465